SOD1 and cancer: SOD enzymes have shown good potential for use in the design of therapeutic molecules for the treatment of cancer and other pathologies related to oxidative stress; however, exogenous SOD has shown low bioavailability, mainly when applied orally, since the acidic pH and the proteases of the stomach cause its denaturation and degradation [71].